Cho Hyeseon, Kelsall Brian L
Mucosal Immunobiology Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Immunol Rev. 2014 Jul;260(1):145-67. doi: 10.1111/imr.12195.
Type I interferons are a widely expressed family of effector cytokines that promote innate antiviral and antibacterial immunity. Paradoxically, they can also suppress immune responses by driving production of anti-inflammatory cytokines, and dysregulation of these cytokines can contribute to host-mediated immunopathology and disease progression. Recent studies describe their anti-inflammatory role in intestinal inflammation and the locus containing IFNAR, a heterodimeric receptor for the type I interferons has been identified as a susceptibility region for human inflammatory bowel disease. This review focuses on the role of type I IFNs in the intestine in health and disease and their emerging role as immune modulators. Clear understanding of type I IFN-mediated immune responses may provide avenues for fine-tuning existing IFN treatment for infection and intestinal inflammation.
I型干扰素是一类广泛表达的效应细胞因子家族,可促进先天性抗病毒和抗菌免疫。矛盾的是,它们还可通过驱动抗炎细胞因子的产生来抑制免疫反应,而这些细胞因子的失调会导致宿主介导的免疫病理学和疾病进展。最近的研究描述了它们在肠道炎症中的抗炎作用,并且已确定含有IFNAR(I型干扰素的异二聚体受体)的基因座是人类炎症性肠病的易感区域。本综述重点关注I型干扰素在肠道健康和疾病中的作用及其作为免疫调节剂的新出现的作用。清楚了解I型干扰素介导的免疫反应可能为微调现有的针对感染和肠道炎症的干扰素治疗提供途径。